COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:39, il y a 5 mois 23 jours Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research initiates coverage on Northwest Biotherapeutics Inc., providing insights into the company's late-stage oncology developments including the promising DCVax-L immunotherapy for glioblastoma First Berlin Equity Research Northwest Biotherapeutics Inc. DCVax-L Immunotherapy Late-stage Oncology Developments USD 1.00 Price Target
COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:30, il y a 5 mois 23 jours EQS-Adhoc: Sibanye Gold Limited: USD 500,000,000 4.250 per cent. Guaranteed Unsecured Convertible Bonds due 2028 Sibanye Gold Limited announces adjustment of Conversion Price for USD 500,000,000 4.250% Guaranteed Unsecured Convertible Bonds due 2028 Convertible Bonds Dividend Conversion Price Adjustment Sibanye Gold Limited
COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:28, il y a 5 mois 23 jours Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.09% stake in JTC plc as of 23 March 2026. Details in Form 8.3 under Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure JTC Plc
COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:27, il y a 5 mois 23 jours Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses a 1.28% interest in Bluefield Solar Income Fund Limited as of 23 March 2026 Disclosure The Vanguard Group Interest Bluefield Solar Income Fund Limited 1.28%
COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:27, il y a 5 mois 23 jours Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% interest in Beazley plc's 5p ordinary securities as of 23 March 2026 Disclosure The Vanguard Group Interest Beazley Plc 5p Ordinary Securities
COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:26, il y a 5 mois 23 jours Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.54% interest in Schroders plc's 20p ordinary securities as of 23 March 2026 The Vanguard Group, Inc. Disclosure Schroders Plc 20p Ordinary Securities 2.54% Interest
COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:25, il y a 5 mois 23 jours Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc The Vanguard Group, Inc. discloses 0.94% ownership of Life Science REIT plc's 1p ordinary securities on 23 March 2026 The Vanguard Group, Inc. Ownership Disclosure 1p Ordinary Securities Life Science REIT Plc 23 March 2026
COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:24, il y a 5 mois 23 jours Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% stake in Spire Healthcare Group plc. Details on securities and transactions provided in Form 8.3 Securities Transactions Form 8.3 The Vanguard Group Spire Healthcare Group Plc
COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:24, il y a 5 mois 23 jours Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses ownership of 4.93% stake in Just Group plc as of 23 March 2026. Transactions include purchases and sales of ordinary shares Transactions Ordinary Shares The Vanguard Group Ownership Disclosure Just Group Plc
COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:23, il y a 5 mois 23 jours Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.32% stake in LondonMetric Property plc. Transactions include purchases and sales of 10p ordinary shares LondonMetric Property Plc Vanguard Group Stake Disclosure Share Transactions 10p Ordinary Shares
Publié le 16/09/2026 à 07:00, il y a 8 heures 50 minutes bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Publié le 16/09/2026 à 07:00, il y a 8 heures 50 minutes bioMérieux obtient le marquage CE IVDR de Classe D pour BIOFIRE® Respiratory 2.1 plus Panel et BIOFIRE® FILMARRAY® Pneumonia plus Panel, les deux premiers tests syndromiques intégrant le MERS-CoV à recevoir à cette certification
Publié le 15/09/2026 à 18:00, il y a 21 heures 50 minutes Compte-rendu d’Assemblée Générale Mixte du 10 septembre 2026
Publié le 15/09/2026 à 18:00, il y a 21 heures 50 minutes Report on the Combined General Meeting of the 10th of September 2026
Publié le 15/09/2026 à 17:45, il y a 22 heures 5 minutes EURAZEO COMPLETES THE ACQUISITION OF NETCO GROUP
Publié le 16/09/2026 à 14:00, il y a 1 heure 50 minutes Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Publié le 16/09/2026 à 13:30, il y a 2 heures 20 minutes Sterling Extends Core MEPS Copper Zone to 700m; Intersects 200m of 0.53% CuEq Including 102m of 0.81% CuEq
Publié le 16/09/2026 à 13:23, il y a 2 heures 27 minutes SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Publié le 16/09/2026 à 13:15, il y a 2 heures 35 minutes Impauer Technologies Announces Launch Of New Corporate Website And Provides OTC Symbol Update
